CLINICAL RESEARCH
Dobutamine Stress Echocardiography in Patients With Diabetes Mellitus
Enhanced Prognostic Prediction Using a Simple Risk Score
Nithima Chaowalit, MD*,
Ana Lucia Arruda, MD*,
Robert B. McCully, MD, FACC*,
Kent R. Bailey, PhD* and
Patricia A. Pellikka, MD, FACC*,*
* Mayo Clinic, Rochester, Minnesota. Dr. Chaowalit is currently affiliated with the Siriraj Hospital, Mahidol University, Bangkok, Thailand, and Dr. Arruda is currently affiliated with the Heart Institute (InCor), University of São Paulo Medical School, São Paulo, Brazil
Manuscript received October 14, 2004;
revised manuscript received October 12, 2005,
accepted October 18, 2005.
* Reprint requests and correspondence: Dr. Patricia A. Pellikka, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905
(Email: pellikka.patricia{at}mayo.edu).
OBJECTIVES: We sought to determine the prognostic value of dobutamine stress echocardiography (DSE) for predicting long-term outcomes in a large cohort with diabetes mellitus and to develop a simple risk score using clinical and echocardiographic data.
BACKGROUND: Neither risk scores nor long-term prognostic value of DSE has been described in a large diabetic population.
METHODS: We studied 2,349 patients with diabetes mellitus (1,338 men, 67 ± 11 years of age) during a follow-up of 5.4 ± 2.2 years.
RESULTS: Mortality and morbidity (myocardial infarction and late coronary revascularization) occurred in 1,044 (44%) and 309 (13%) patients, respectively. Addition of stress echocardiographic variables to the clinical and rest echocardiographic model provided incremental prognostic information for predicting mortality (chi-square = 243 to 270, p < 0.0001) and morbidity (chi-square = 38 to 78, p < 0.0001). For each end point, a simple risk score was derived according to the estimated values of beta coefficients of multivariate predictors (insulin therapy, smoking, failure to achieve target heart rate, percentage of ischemic segments, and impaired left ventricular systolic function) and resulted in an assessment of risk among all age groups. The C-statistic values were 0.60 to 0.64, indicating modest discrimination. The estimated five-year event-free survivals of patients in three risk categories were 94%, 86%, and 80% for morbidity (p < 0.00001) and 69%, 60%, and 47% for mortality (p < 0.0001).
CONCLUSIONS: In patients with diabetes mellitus, a simple and practical risk score using clinical variables and results of DSE stratified patients into three risk groups for mortality and cardiovascular morbidity.
This article has been cited by other articles:
|
|
|
|
 
R. Sicari, P. Nihoyannopoulos, A. Evangelista, J. Kasprzak, P. Lancellotti, D. Poldermans, J.-U. Voigt, J. L. Zamorano, and on behalf of the European Association of Echocardi
Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC)
Eur J Echocardiogr,
July 1, 2008;
9(4):
415 - 437.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. J. Bax, L. H. Young, R. L. Frye, R. O. Bonow, H. O. Steinberg, and E. J. Barrett
Screening for Coronary Artery Disease in Patients With Diabetes
Diabetes Care,
October 1, 2007;
30(10):
2729 - 2736.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Gang, M. Dabhi, and M. M. Rajapurkar
Ischaemia imaging in type 2 diabetic kidney transplant candidates is coronary angiography essential?
Nephrol. Dial. Transplant.,
August 1, 2007;
22(8):
2334 - 2338.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. B. Ingul, E. Rozis, S. A. Slordahl, and T. H. Marwick
Incremental Value of Strain Rate Imaging to Wall Motion Analysis for Prediction of Outcome in Patients Undergoing Dobutamine Stress Echocardiography
Circulation,
March 13, 2007;
115(10):
1252 - 1259.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. D. Miller, R. F. Redberg, and F. J.T. Wackers
Screening Asymptomatic Diabetic Patients for Coronary Artery Disease: Why Not?
J. Am. Coll. Cardiol.,
August 15, 2006;
48(4):
761 - 764.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
